Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Permeon Biologics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Permeon Biologics

Permeon Biologics

Seed

Cambridge-based Permeon Biologics develops therapeutic drugs to enhance human health.

HQ
Cambridge, MA, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Permeon Biologics, founded in Cambridge, Massachusetts, is dedicated to developing therapeutic drugs aimed at enhancing human health. The company's core mission is to innovate in the field of biotechnology to create effective treatments for various medical conditions. Permeon Biologics focuses on leveraging advanced biological research to produce high-quality therapeutic solutions that address unmet medical needs.

Notable figures affiliated with Permeon Biologics include leading scientists and industry experts who contribute to its innovative approach. The company has garnered attention from prominent investors in the biotech sector, which has enabled significant advancements in its drug development pipeline. Permeon Biologics' achievements include the successful development of several promising therapeutic candidates, positioning it as a key player in the biotechnology industry and contributing to the broader goal of improving global health outcomes.

Permeon Biologics - Similar Companies

Purinomia Biotech logo

Purinomia Biotech

purinomia.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Cogent Biosciences logo

Cogent Biosciences

cogentbio.com

ProThera Biologics logo

ProThera Biologics

Solarea Bio logo

Solarea Bio

solareabio.com

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

Faze Medicines logo

Faze Medicines

fazemed.com

Merganser Biotech logo

Merganser Biotech

Petri Bio logo

Petri Bio

petribio.com

Extend Biosciences logo

Extend Biosciences

extendbio.com

Rekindle Therapeutics logo

Rekindle Therapeutics

Peel Therapeutics logo

Peel Therapeutics

peeltx.com

Symic Biomedical logo

Symic Biomedical

Skye Bioscience logo

Skye Bioscience

Walden Biosciences logo

Walden Biosciences

Permeon Biologics - Quick Facts

Who are Permeon Biologics' competitors?

Companies similar to Permeon Biologics include Purinomia Biotech, ProFound Therapeutics, Cogent Biosciences and ProThera Biologics.

When was Permeon Biologics founded?

Permeon Biologics was founded in 2011.

Where is Permeon Biologics' headquarters located?

Permeon Biologics' headquarters is located in Cambridge, MA, US.

When was Permeon Biologics' last funding round?

Permeon Biologics' most recent funding round was for $2.5M (USD) in December 2011.

How much has Permeon Biologics raised to-date?

As of Dec 30, 2011, Permeon Biologics has raised a total of $2.5M (USD).

How many employees does Permeon Biologics have?

Permeon Biologics has 11 employees as of Feb 5, 2024.

Permeon Biologics - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutic Drugs
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 15 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified